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Primary varicella infection (chicken pox) is an acute but benign disease in childhood. Varicella virus can also become latent in the ganglion of nerve cells, both sensory 
and motor, after primary infection, and when the cell-mediated 
immunity and neutralizing antibodies are unable to keep it 
under control, it gets reactivated as herpes zoster. Malignancy, 
immunosuppressive drugs or radiation, trauma, stress often trigger 
reactivation [1]. Immunocompromised children are not only at an 
increased risk of reactivation of varicella, the complication rate, 
and mortality is also increased by many folds [2].
Staphylococcal scalded skin syndrome (SSSS) is a toxin-
mediated, blistering dermatitis caused by infection with 
some particular toxin producing strains of Staphylococcus 
aureus. This syndrome may present in a wide variety of skin 
manifestation ranging from bullous impetigo, scarlatiniform rash, 
to a generalized desquamative process; again, it might be very 
deceptive in the presence of underlying immunodeficiency and 
other skin conditions. Mortality in childhood SSSS is <10%; 
however, in the setting of immunosuppression, it can rapidly lead 
to multi-organ failure and death [3].
The two above-mentioned conditions can complement each 
other as loss of skin barrier from recurrent varicella lesions may 
provide a favorable medium for S. aureus to thrive and produce 
toxins [4].
We report a case of SSSS complicating recurrent varicella 
infection in a pediatric oncology patient, treated successfully with 
a combination of early and appropriate antiviral and antibacterial 
agents coupled with aggressive supportive care.
With the advances in modern medicine, increasing number of 
immunosuppressed children are being cared for by pediatricians. 
These children being prone to such atypical clinical course of 
diseases are expected to pose significant challenges. Our case 
may help in early suspicion of similar cases where the prompt 
diagnosis, based mainly on clinical judgment coupled with 
aggressive management is the key to a successful outcome.
CASE REPORT
A 3-year-old male child, diagnosed as a case of B-cell acute 
lymphoblastic leukemia 6 months back was receiving treatment 
with standard chemotherapy protocol, currently on “repeat 
induction” cycle. He received the last dose of chemotherapy 
with L-asparaginase 1 week back. The child was admitted with 
complaints of fever for 4 days, generalized rash, with peeling of 
skin and bleeding from skin lesions. The lesions started as small 
vesicles over the abdomen and rapidly spread over the whole 
body with blister formation. There was a history of chicken pox 
3 months back and he was not immunized with the varicella-zoster 
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vaccine (VZV). On examination, there were vesicobullous 
lesions spread all over the body, including palms and soles with 
surrounding erythema (Fig. 1a) and multiple flaccid blisters 
(Fig. 1b). There was no involvement of mucosal surfaces. Child’s 
vital parameters and systemic examination were within normal 
limits. Dermatological consultation was sought and a diagnosis 
of reactivation of varicella was considered as Tzanck smear 
revealed multinucleated giant cells with intranuclear inclusions. 
Investigations revealed an absolute neutrophil count of zero 
with thrombocytopenia (platelet count 32,000/mm3) and anemia 
(hemoglobin 8.3 g/dl), though renal and liver function parameters 
were within normal limits. He was started on IV antibiotics 
(injection piperacillin-tazobactam and injection amikacin) and 
injection acyclovir. There was clinical improvement (decrease in 
fever and no new skin lesions) over next 72 h. However, after 
another 24 hours, there was a recurrence of fever and worsening 
of skin lesions with the development of large bullae filled with 
clear fluid on the nape of the neck and upper back. The child also 
had areas of erosion over the body with serosanguinous exudates. 
Over next 24 h, he also developed septic shock manifesting with 
tachycardia, tachypnea, bounding pulses, and wide pulse pressure 
requiring intravenous (IV) fluid boluses followed by inotropic 
support with noradrenaline. He also developed abnormal 
bleeding in the form of malena and the laboratory investigations 
(platelet count 5,000/mm3, prothrombin time 21 s, INR 1.9, 
activated partial thromboplastin time 58 s, fibrinogen degradation 
products 53 mcg/ml, d-dimer >0.5 mcg/ml) were suggestive of 
disseminated intravascular coagulation (DIC). It was managed 
with fresh frozen plasma (FFP) transfusion. A diagnosis of 
secondary infection with possible SSSS was considered. As 
the initial blood culture was sterile, empirical up gradation of 
antibiotics was done to include clindamycin. Acyclovir was 
continued along with aggressive supportive measures in the 
form of inotrope, growth factor (granulocyte colony stimulating 
factor), and blood component therapy (packed red blood cell and 
single donor platelet). Skin lesions were managed with sterile 
wrappings and semi-permeable dressings along with topical 
antistaphylococcal antibiotic (mupirocin). Repeat blood culture 
was also sterile, but skin swab culture showed abundant growth 
of methicillin-sensitive S. aureus (MSSA). Skin punch biopsy 
and histopathological examination demonstrated intraepidermal 
cleavage under stratum corneum with little inflammatory 
infiltrate, confirming the diagnosis of SSSS. Over next 48 h, he 
showed signs of improvement and inotrope could be tapered and 
stopped. He became afebrile after another 3 days. He was given 
IV antibiotics and acyclovir for 14 days followed by acyclovir 
prophylaxis. Reepithelization of the denuded skin began 2 weeks 
after admission, and the child could be discharged after 4 weeks. 
Complete reepithelization of the skin occurred in 6 weeks. Now, 
after 1 year of follow-up, the child is currently on maintenance 
cycle of chemotherapy and did not have further reactivation of 
varicella infection.
DISCUSSION
The incidence of infection with herpes viruses is greatly increased 
in immunocompromised hosts [5]; they are also at a higher risk 
of developing atypical/disseminated/extended infection with 
these viruses [2,5]. Atypical characteristics of skin lesions in 
immunocompromised patients include atypical locations, larger 
size of lesions, deeper, ulceration, satellite lesions, hemorrhagic 
lesion, and longer healing time [6]. The ulcerative-necrotic-
gangrenous variety of zoster lesions is described exclusively in 
immunocompromised patients. The pathogenesis of such bullous 
lesions remains unclear and has been attributed to coinfecting 
exfoliative cytotoxin-producing organisms [7]. Our patient being 
persistently immunocompromised secondary to leukemia and 
its therapy, had recurrence/atypical reactivation of his varicella 
infection. Pneumonitis, hepatitis, pancreatitis, encephalitis, 
myocarditis, and DIC may occur with visceral dissemination 
in immunocompromised host [2]. Although the index child had 
some risk factors associated with increased risk of complications 
such as age <5 years and severe neutropenia [2], fortunately, he 
had none of the above-mentioned systemic involvement except 
DIC. Bacterial superinfection is the most common complication, 
seen in around 50% of cases of varicella, with S. aureus and beta-
hemolytic streptococci being the most common causes [8,9]. Skin 
barrier disruption and virus-induced alteration of local immunity 
predispose to bacterial superinfection. Most of the staphylococcus-
induced lesions in varicella are toxin-mediated [9]. Apart from 
symptomatic and supportive measures, management of varicella 
in immunocompromised, either primary or recurrent, consists 
of acyclovir therapy for 10-14 days [10], which our patient 
also received. Prevention (primary and secondary) of varicella 
infection in immunocompromised patients is an area of debate. 
The options include immunization, post-exposure prophylaxis 
with varicella-zoster immunoglobulin (VZIG) and antiviral 
agent (generally acyclovir) given either post-exposure or long-
term [11]. Recommendations for VZV, a life-attenuated vaccine, 
in immunocompromised differ across the guidelines, though its 
efficacy seems to be of no concern [12]. Cost and availability limit 
Figure 1: (a) Ruptured vesicobullous lesions of varicella with scars 
of previous chicken pox, (b) large hemorrhagic blister with necrotic 
epidermis over shin region
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the use of VZIG, especially in the developing countries. Acyclovir 
used as a long-term prophylaxis has been shown to be effective 
in immunosuppressed [11]. Our patient, having a recurrence 
of varicella infection with a life-threatening complication was 
considered for the long-term prophylactic therapy.
In general, children have a prodrome of fever and malaise 
before developing skin lesions of SSSS. Nikolsky sign may be 
positive even before skin lesions are obvious. Coxsackie virus-
induced blistering lesion, toxic epidermal necrolysis, drug 
reaction with eosinophilia, and Kaposi’s varicelliform eruption 
or eczema herpeticum are the differential diagnoses. Time of 
onset and lack of mucosal involvement help in ruling out these 
conditions aided by a positive culture of S. aureus and skin biopsy. 
Eczema herpeticum (EH) is a disseminated herpes viral infection 
on a pre-existing skin disease, most commonly atopic dermatitis; 
but also with psoriasis, eczema, irritant contact dermatitis, burns, 
and seborrheic dermatitis [13]. EH is also known to have a severe 
course in immunocompromised children and frequently develops 
a secondary staphylococcal infection. However, our child did not 
have any pre-existing skin lesion.
IV fluid, correction of electrolyte disturbance, antibiotics, and 
local wound management remain the mainstay of management 
in SSSS. Penicillinase-resistant penicillin is the ideal first line 
as the majority of SSSS is caused by MSSA, though there has 
been increasing incidence of methicillin-resistant strains [3]. 
If there is no improvement or worsening, vancomycin to cover 
MRSA should be considered. Clindamycin and linezolid may be 
beneficial by toxin inhibition. Other adjuvant therapies, such as 
IV immunoglobulin or FFP may help in neutralizing exotoxin [3]. 
Our patient received FFP transfusion as he also had DIC. Dressing 
with saline-soaked gauze over soft silicone primary dressing of 
denuded skin prevents fluid loss and secondary infection. There 
is also a need for searching the primary site of infection with 
S. aureus, which is usually upper respiratory tract in children [3].
CONCLUSION
Immunocompromised children are at increased risk of reactivation 
of varicella infection and various complications thereof. SSSS 
can present as a complication of varicella infection, often posing 
a diagnostic and therapeutic challenge. Early and aggressive 
antimicrobial therapy along with good supportive care is the key 
in the management of such cases.
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